EUGENE KARPUS: Open Payments
NPI 1831239920 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 8 payments from 5 companies in 2025. Trend: 2023 $2,092 · 2024 $1,887 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $366 |
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
| Alkermes, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
Products named: REXULTI, COBENFY, LYBALVI, ABILIFY MAINTENA, AUSTEDO XR, Auvelity.
Industry payments across CA — which companies pay providers there.
